BIOMERIEUX (BIM.PA) Stock Income Statement
EPA:BIM - Euronext Paris - Matif - FR0013280286 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.98B | 3.67B | 3.59B | 3.38B | 3.12B | |||
| Minority Interest Expense | 7.10M | 34.80M | 11.80M | 2.90M | 1.70M | |||
| Cost Of Goods | 1.76B | 1.62B | 1.58B | 1.38B | 1.36B | |||
| Gross Profit | 2.22B | 2.06B | 2.01B | 2.00B | 1.75B | |||
| Operating Expenses | 1.60B | 1.50B | 1.42B | 1.22B | 1.20B | |||
| Research and Development | 491.50M | 460.10M | 446.60M | 385.80M | 398.80M | |||
| Selling, General, and Administrative Expenses | 1.10B | 1.02B | 954.70M | 815.60M | 789.30M | |||
| Operating Income | 611.70M | 561.10M | 587.20M | 784.30M | 552.80M | |||
| Interest Income/Expense | -19.80M | 1.40M | -4.30M | -11.70M | -29.10M | |||
| Other Income/Expense | 10.40M | 300.00K | -2.30M | 1.30M | 1.20M | |||
| Non Recurring Items | -22.90M | -125.50M | N/A | 600.00K | -600.00K | |||
| Income Before Taxes | 579.40M | 437.30M | 580.60M | 774.50M | 524.30M | |||
| Income Tax | 154.30M | 114.50M | 140.10M | 175.60M | 121.50M | |||
| Net Income | 432.20M | 357.60M | 452.40M | 601.10M | 404.40M | |||
| EBITDA | 936.90M | 731.20M | 654.20M | 843.10M | 763.60M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 3.64 | 3.01 | 3.82 | 5.06 | 3.41 | |||
| Non GAAP EPS | 3.86 | N/A | 3.82 | 5.08 | 3.41 | |||
| Statistics | ||||||||
| Gross Profit Margin | 55.66% | 55.99% | 55.97% | 59.26% | 56.24% | |||
| Profit Margin | 10.86% | 9.73% | 12.60% | 17.80% | 12.97% | |||
| Operating Profit Margin | 15.37% | 15.27% | 16.36% | 23.23% | 17.73% | |||
All data in EUR